(NP (NP (NP-COOD (NP Glucocorticoid/NN receptor/NN) and/CC (NP (NP inhibition/NN) (PP of/IN (NP 3-O-methyl-D-glucose/NN uptake/NN)) (PP by/IN (NP glucocorticoids/NNS)))) (PP in/IN (NP (NP peripheral/JJ blood/NN leukocytes/NNS) (PP from/IN (NP normal/JJ humans/NNS)))) :/:) (NP (NP correlation/NN) (PP between/IN (NP (NP-COOD (NP receptor/NN level/NN) and/CC (NP hormone/NN effect/NN)) (ADVP in/FW vitro/FW))) ./.))
(S (NP-SBJ We/PRP) (VP have/VBP (VP measured/VBN (NP (NP the/DT glucocorticoid/NN receptor/NN concentration/NN) (PP in/IN (NP (NP (ADJP-COOD (ADJP mononuclear/JJ) and/CC (ADJP polymorphonuclear/JJ)) leukocytes/NNS) ,/, (SBAR (WHNP-51 (NP both/DT) (WHPP of/IN (WHNP which/WDT))) (S (NP-SBJ-52 *T*-51/-NONE-) (VP were/VBD (VP isolated/VBN (NP *-52/-NONE-) (PP from/IN (NP (NP peripheral/JJ blood/NN) (PP from/IN (NP ten/CD healthy/JJ male/JJ volunteers/NNS))))))))))))) ./.)
(S (PP In/IN (NP parallel/NN)) ,/, (NP-SBJ-53 (NP the/DT inhibitory/JJ effect/NN) (PP of/IN (NP dexamethasone/NN)) (PP on/IN (NP 3-O-methyl-D-glucose/NN uptake/NN))) (VP was/VBD (VP assayed/VBN (NP *-53/-NONE-) (PP in/IN (NP the/DT corresponding/JJ mononuclear/JJ leukocytes/NNS)))) ./.)
(S-COOD (S (NP-SBJ (NP The/DT glucocorticoid/NN receptor/NN levels/NNS) (PP in/IN (NP mononuclear/JJ leukocytes/NNS))) (VP correlated/VBD (PP with/IN (NP (NP those/DT) (PP in/IN (NP polymorphonuclear/JJ leukocytes/NNS)))))) ,/, and/CC (S (NP-SBJ there/EX) (VP was/VBD (NP-PRD a/DT linear/JJ relationship/NN) (PP between/IN (NP (NP (NP-COOD (NP the/DT cellular/JJ glucocorticoid/NN receptor/NN levels/NNS) and/CC (NP (NP glucocorticoid-mediated/JJ inhibition/NN) (PP of/IN (NP (NP the/DT uptake/NN) (PP of/IN (NP 3-O-methyl-D-glucose/NN))))))) (PP in/IN (NP mononuclear/JJ leukocytes/NNS)))))) ./.)
(S (SBAR-TMP (WHADVP-54 When/WRB) (S (NP-SBJ-55 mononuclear/JJ leukocytes/NNS) (VP were/VBD (VP incubated/VBN (NP *-55/-NONE-) (PP in/IN the/DT presence/NN of/IN (NP 8-bromo-cAMP/NN)) (ADVP *T*-54/-NONE-))))) ,/, (S-COOD (S (NP-SBJ cellular/JJ glucocorticoid/NN receptor/NN levels/NNS) (VP increased/VBD)) and/CC (S (NP-SBJ-56 (NP a/DT (ADJP more/RBR pronounced/JJ) inhibitory/JJ effect/NN) (PP of/IN (NP dexamethasone/NN))) (VP was/VBD (VP observed/VBN (NP *-56/-NONE-) (PP on/IN (NP (NP the/DT transport/NN) (PP of/IN (NP 3-O-methyl-D-glucose/NN)))))))) ./.)
(S (NP-SBJ We/PRP) (VP conclude/VBP (SBAR-COOD (SBAR that/IN (S (NP-SBJ (NP the/DT cellular/JJ glucocorticoid/NN receptor/NN levels/NNS) (PP in/IN (NP peripheral/JJ blood/NN leukocytes/NNS))) (VP reflect/VBP (NP (NP (ADJP in/FW vitro/FW) responsiveness/NN) (PP to/TO (NP (NP glucocorticoids/NNS) (PP in/IN (NP (NP mononuclear/JJ leukocytes/NNS) (PP from/IN (NP healthy/JJ males/NNS)))))))))) ,/, and/CC (SBAR that/IN (S (NP-SBJ the/DT individual/JJ responsiveness/NN) (VP may/MD (VP alter/VB (PP-TMP upon/IN (NP (NP changes/NNS) (PP in/IN (NP (NP the/DT cellular/JJ levels/NNS) (PP of/IN (NP glucocorticoid/NN receptor/NN)))))))))))) ./.)
